Patent Law Practice Center

Caraco v. Novo Nordisk: Supreme Court Alters the Landscape of Hatch-Waxman Litigation

On Monday, May 7th, PLI will be hosting a One Hour Briefing entitled, “Caraco v. Novo Nordisk: Supreme Court Alters the Landscape of Hatch-Waxman Litigation by Adopting Expansive Interpretation of Counterclaims Provision.“  This briefing will be conducted by Elaine Herrmann Blais and Robert D. Carroll, partners in the law firm Goodwin Procter LLP. The U.S. Supreme Court’s decision in Caraco Pharmaceutical Laboratories Ltd. v. Novo Nordisk A/S, clarified the circumstances in which generic drug companies can challenge the scope of the “use codes” for the patents that branded drug companies list in the FDA’s “Orange Book.” (more…)